Hemodynamic Parameters in People with Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Not Applicable

Recruiting

• Conditions: Peripheral Artery Disease (PAD); Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)); Cerebrovascular Atherosclerosis

• Registration Number: NCT06701032
• Lead Sponsor: Laval University

Brief Summary

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).

Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-11-20
• Study First Submitted QC: 2024-11-20
• Study First Posted: 2024-11-22
• Study Start: 2024-11-25
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-03
• Last Update Posted: 2025-03-06
• Primary Completion: 2025-06
• Study Completion: 2026-03

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
• Have been admitted to the PREV program;

Exclusion Criteria

• Being not able to give written informed consent;

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Change in toe pressure measurement	Change from baseline to 12 weeks	Results will be measured in mm Hg
Change in the toe-brachial index	Change from baseline to 12 weeks
Change in the ankle-brachial index	Change from baseline to 12 weeks

Secondary Outcome Measures

Name	Time	Method
Change in 6-minute walk test (6MWT)	Change from Baseline to 12 weeks	Results will be measured in meters
Short Form Health Survey 36 (SF-36)	Change from baseline to 12 weeks	Change in quality of life measured using the SF-36 questionnaire. The scores range from 0-100.

Trial Locations

Locations (1)

CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches; 🇨🇦 Lévis, Quebec, Canada